In the meanwhile, EMT promotes mesenchymal and stem-like phenotype of cancer cells and alters tumor microenvironment via autocrine and paracrine signaling, resulting in a constitutive activation of NF-κB in a ligand-receptor manner rather than genetic alteration [24]. Here, NFKB1 is linked to cancer.